Micronucleus Test on Amrubicin Hydrochloride(SM-5887) in CD-1 Mice.

Accession number;99A0241099
Title;Micronucleus Test on Amrubicin Hydrochloride(SM-5887) in CD-1 Mice.
Author; HARA MASAKI (Sumitomo Chemical Co., Ltd.) OTA MIKA (Sumitomo Chemical Co., Ltd.) ODAWARA KYOKO (Sumitomo Chemical Co., Ltd.)
Journal Title;Japanese Pharmacology & Therapeutics
Journal Code:Z0947A
ISSN:0386-3603
VOL.27;NO.Suppl.1;PAGE.S.509-S.512(1999)
Figure&Table&Reference;TBL.1, REF.10
Pub. Country;Japan
Language;Japanese
Abstract;Amrubicin hydrochloride(SM-5887) was examined for its potential to induce micronuclei in bone marrow cells of male mice. Eight-week-old male mice of CD-1 strain were used in a micronucleus test, and each group consisted of 5 animals. SM-5887 was administered to mice at single intrepenetrial doses of 0.5, 1,2,5 and 10mg/kg, and bone marrow smears were made 24 hours after administration. The test material induced dose-related and significant increases in the incidence of micronucleated polychromatic erythrocytes(MNPCEs) in mice. A positive control chemical, mitomycin C(1mg/kg, ip, 24 hours), induced marked increases in the incidence of micronuclei. From the above findings, it is concluded that SM-5887 has a potential to induce micronuclei in mouse bone marrow cells under the conditions tested. (author abst.)